What is myMTMcare?
myMTMcare operates at the intersection of clinical pharmacy and health plan administration, providing custom-tailored medication therapy management (MTM) programs. The company distinguishes itself through a high-touch, empathetic engagement model that prioritizes patient-centered care. By deploying experienced pharmacists to conduct comprehensive medical reviews, myMTMcare addresses critical challenges such as medication adherence and dosage optimization. This approach not only enhances patient safety but also serves as a vital lever for health plans to improve their star ratings and achieve meaningful reductions in overall healthcare expenditures.
How much funding has myMTMcare raised?
myMTMcare has raised a total of $299K across 2 funding rounds:
Debt
$150K
Debt
$149K
Debt (2020): $150K with participation from PPP
Debt (2021): $149K led by PPP
Key Investors in myMTMcare
PPP
Public-Private Partnership
What's next for myMTMcare?
With this late-stage capital, myMTMcare is poised to accelerate its technological infrastructure and expand its clinical service footprint. The strategic focus will likely shift toward enhancing the scalability of its MTM platform, ensuring that the personalized care model remains effective as the client base grows. By continuing to demonstrate measurable improvements in patient health outcomes and cost-efficiency, the company is strengthening its value proposition for health plans navigating an increasingly complex regulatory and financial landscape. Future initiatives will likely prioritize the integration of advanced data analytics to further refine medication safety protocols and patient engagement strategies.
See full myMTMcare company page
